Ligand Pharmaceuticals Inc. (LGND) — Analysis Summary
Ligand Pharmaceuticals Inc. (LGND) has a market cap of $4.65B with year-over-year revenue growth of +60.4%. Net margin stands at 46.4%. The stock trades at a P/E ratio of 30.3.
Key Takeaways
- Revenue changed +60.4% year-over-year
- Net margin of 46.4%
- P/E ratio of 30.3
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, LGND posted revenue growth of +60.4% and trades at a P/E of 30.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.